Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies

International Journal of Cancer

Volumn 87, Issue 1, 2000, Pages 86-94

  Keppler Hafkemeyer, Andrea ^a   Kreitman, Robert J ^a   Pastan, Ira ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; INTERLEUKIN 2; RECEPTOR SUBUNIT;

APOPTOSIS; ARTICLE; BLOOD DISEASE; CELL DEATH; CELL DIFFERENTIATION; DISULFIDE BOND; DRUG EFFECT; ENZYME SUBSTRATE; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION;

AMINO ACID CHLOROMETHYL KETONES; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; APOPTOSIS; BURKITT LYMPHOMA; CASPASE 3; CASPASES; CELL ADHESION MOLECULES; CELL SURVIVAL; COUMARINS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOLOGIC NEOPLASMS; IMMUNOBLOTTING; IMMUNOTOXINS; LECTINS; LEUCINE; LEUKEMIA; LYMPHOMA, T-CELL; OLIGOPEPTIDES; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED;

EID: 0034119870     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000701)87:1<86::AID-IJC13>3.0.CO;2-I     Document Type: Article

References (26)

1. ALNEMRI, E.S., LIVINGSTON, D.J., NICHOLSON, D.W., SALVESEN, G., THORNBERRY, N.A., WONG, W.W. and YUAN, J., Human ICD-CED-3 protease nomenclature. Cell, 87, 171 (1996).
2. BRINKMANN, U., BRINKMANN, E., GALLO, M., SCHERF, U. and PASTAN, I., Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry, 35, 6891-6899 (1996).
3. BRINKMANN, U., MANSFIELD, E. and PASTAN, I., Effects of BCL-2 overexprRession on the sensitivity of MCF-7 breast cancer cells to ricin, diphtheria and Pseudomonas toxin and immunotoxins. Apoptosis, 2, 192-198 (1997).
4. BRINKMANN, U., PAI, L.H., FITZGERALD, D.J. and PASTAN, I., B3(Fv)-PE38KDEL, a single chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. nat. Acad. Sci. (Wash.), 88, 8616-8620 (1991).
5. BUCHNER, J., PASTAN, I. and BRINKMANN, U., A method to increase the yield of properly folded recombinant fusion proteins, e.g., single-chain immunotoxins from renaturations of bacterial inclusion bodies. Anal. Biochem., 205, 263-270 (1992).
6. CARROLL, S. and COLLIER, R., Active site of Pseudomonas aeruginosa exotoxin A. J. Biol. Chem., 262, 8707-8711 (1987).
7. CHANG, M.P., BRAMHALL, J., GRAVES, S., BONAVIDA, B. and WISNIESKI, B., Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. J. Biol. Chem., 264, 15261-15267 (1989).
8. CHAUDHARY, V.K., QUEEN, C., JUNGHANS, R.P., WALDMANN, T.A., FITZGERALD, D.J. and PASTAN, I., A recombinant immunotoxin consisting of 2 antibody variable domains fused to Pseudomonas exotoxin. Nature (Lond.), 339, 394-397 (1989).
9. DIVE, C., Avoidance of apoptosis as a mechanism of drug resistance. J. intern. Med., 242, 139-145 (1997).
10. ENARI, M., TALANIAN, R.V., WONG, W.W. and NAGATA, S., Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380, 723-726 (1996).
11. HARA, H., FRIEDLANDER, R.M., GAGLIARDINI, V., AYATA, C., FINK, K., HUANG, Z., SHIMIZU-SASAMATA, M., YUAN, J. and MOSKOWITZ, M., Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. nat. Acad. Sci. (Wash.), 94, 2007-2012 (1997).
12. JAFFRÉZOU, J.-P., BETTAIEB, A., LEVADE, T. and LAURENT, G., Antitumor agent-induced apoptosis in myeloid leukemia cells: a controlled suicide. Leukemia Lymphoma, 29, 453-463 (1998).
13. KEPPLER-HAFKEMEYER, A., BRINKMANN, U. and PASTAN, I., Role of caspases in immunotoxin-induced apoptosis of cancer cells. Biochemistry, 37, 16934-16942 (1998).
14. KREITMAN, R.J., CHAUDHARY, V.K., WALDMANN, T.A., HANCHARD, B., CRANSTON, B., FITZGERALD, D.J. and PASTAN, I., Cytotoxic activities of recombinant toxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia, 7, 553-562 (1993).
15. KREITMAN, R.J. and PASTAN, I., Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either Pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells. Blood, 90, 252-259 (1997).
16. KREITMAN, R.J., WANG, Q.-C., FITZGERALD, D.J.P. and PASTAN, I., Complete regression of human β-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. Int. J. Cancer, 81, 148-155 (1999a).
17. KREITMAN, R.J., WILSON, W.H., ROBBINS, D., MARGULIES, I., STETLER-STEVENSON, M., WALDMANN, T.A. and PASTAN, I., Responses in refractory hairy cell leukemia to a recombinant immunotoxin. Blood, 94, 3340-3348 (1999b).
18. LAZEBNIK, Y.A., KAUFMANN, S.H., DESNOYERS, S., POIRIER, G.G. and EARNSHAW, W., Cleavage of poly(ADP-ribose) polymerase with properties like ICE. Nature (Lond.), 371, 346-347 (1994).
19. MANSFIELD, E., AMLOT, P., PASTAN, I. and FITZGERALD, D., Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors. Blood, 90, 2020-2026 (1997).
20. MARTINS, L.M. and 14 OTHERS, Activation of multiple interleukin 1-β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. biol. Chem., 272, 7421-7430 (1997).
21. PASTAN, I. and FITZGERALD, D., Pseudomonas exotoxin: chimeric toxins. J. biol. Chem., 264, 15157-15160 (1989).
22. PASTAN, I. and FITZGERALD, D., Recombinant toxins for cancer treatment. Science, 254, 1173-1177 (1991).
23. RODRIQUEZ, I., MATSUURA, K., ODY, C., NAGATA, S. and VASSALLI, P., Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. exp. Med., 184, 2067-2072 (1996).
24. THORNBERRY, N.A. and LAZEBNIK, Y., Caspases: enemies within. Science, 281, 1312-1316 (1998).
25. WALDMANN, T.A., The promiscuous IL-2IL-15 receptor: a target for immunotherapy of HTLV-1-associated disorders. J. Acquir. Immune Defic. Syndr. hum. Retrovirol., 13 (Suppl. 1), S179-S185 (1996).
26. YAOITA, H., OGAWA, I., MAEHARA, K. and MARUYAMA, Y., Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation, 97, 276-281 (1998).